Yabro is a nebulization solution that contains 0.3% sodium hyaluronate, a moisturizing agent derived from hyaluronic acid and sodium.
It has shown significant improvements in pediatric patients with recurrent upper respiratory tract disorders compared to traditional saline solutions.
IBSA recommends its use in nasal aerosol therapy, as periodic nebulizations promote:
- The elimination of allergens.
- The restoration of mucociliary clearance.
This is especially important during the postoperative period of endonasal interventions.
